Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Hair restoration surgery in patients with prior neurosurgery or radiation treatment can have risks like infection and poor wound healing, so it's important to discuss these with the patient.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Propylthiouracil treatment can cause hair loss.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Ayurveda-based care with Guduchi, Ashwagandha, and Curcumin improved quality of life for breast cancer patients without serious side effects.